Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Exosome Journey: From Biogenesis to Regulation and Function in Cancers. | J Oncol | 2022 | 35898929 | PubTator, text mining | PubMed |
| The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype? | Ther Adv Hematol | 2022 | 35898435 | PubTator, text mining | PubMed |
| Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer. | Adv Sci (Weinh) | 2022 | 35896951 | PubTator, text mining | PubMed |
| Proteomic and phosphoproteomic landscapes of acute myeloid leukemia. | Blood | 2022 | 35895896 | PubTator, text mining | PubMed |
| Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. | J Thromb Haemost | 2022 | 35894106 | PubTator, text mining | PubMed |
| In Pursuit of Genetic Prognostic Factors and Treatment Approaches in Secondary Acute Myeloid Leukemia-A Narrative Review of Current Knowledge. | J Clin Med | 2022 | 35893374 | PubTator, text mining | PubMed |
| High-Throughput CRISPR Screening in Hematological Neoplasms. | Cancers (Basel) | 2022 | 35892871 | PubTator, text mining | PubMed |
| Multiple Simultaneous Infections With Nontuberculous Mycobacteria in the Setting of GATA2 Mutation and Myelodysplastic Syndrome. | Open Forum Infect Dis | 2022 | 35891688 | PubTator, text mining | PubMed |
| Spontaneous Remission of Acute Myeloid Leukemia: A Case Report. | Medicina (Kaunas) | 2022 | 35888640 | PubTator, text mining | PubMed |
| A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights. | Int J Mol Sci | 2022 | 35887218 | PubTator, text mining | PubMed |
| Use of Publication Dynamics to Distinguish Cancer Genes and Bystander Genes. | Genes (Basel) | 2022 | 35885888 | PubTator, text mining | PubMed |
| Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications. | Diagnostics (Basel) | 2022 | 35885563 | PubTator, text mining | PubMed |
| Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process. | Diagnostics (Basel) | 2022 | 35885562 | PubTator, text mining | PubMed |
| Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease. | Diagnostics (Basel) | 2022 | 35885518 | PubTator, text mining | PubMed |
| Myelodysplastic Syndrome: Diagnosis and Screening. | Diagnostics (Basel) | 2022 | 35885487 | PubTator, text mining | PubMed |
| Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies. | Cancers (Basel) | 2022 | 35884491 | PubTator, text mining | PubMed |
| Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. | Cancers (Basel) | 2022 | 35884368 | PubTator, text mining | PubMed |
| Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells. | Biomolecules | 2022 | 35883549 | PubTator, text mining | PubMed |
| Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets. | Gynecol Oncol Rep | 2022 | 35880223 | PubTator, text mining | PubMed |
| Cooperative engagement and subsequent selective displacement of SR proteins define the pre-mRNA 3D structural scaffold for early spliceosome assembly. | Nucleic Acids Res | 2022 | 35871302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=44